-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g2-3.xlsx
January 01, 2022 - No Some concerns Yes Yes No NA NA Yes NA Low Yes 21.7% for T3, 8.3-10% for T2 (CAPS/PDS)
overall not analyzed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - this decision to differentially affect
results for OCs compared to the other cancers of interest,
we analyzed
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017034-chrischilles-final-report-2011.pdf
January 01, 2011 - Management Focus Groups
Transcripts and notes from patient, caregiver, and provider focus groups were analyzed
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/3MSummaryResultsReportFinal.jsp
October 03, 2010 - Risk adjusted models were created and analyzed using the following hospital administrative and clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
November 27, 2012 - 322 achieved an early
virological response and were actually randomized to
different treatments and analyzed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
March 01, 2013 - We analyzed data using Review Manager
(RevMan) version 5.1 software.34 We used random effects
models
-
www.ahrq.gov/sites/default/files/2025-03/taylor-report.pdf
January 01, 2025 - Due to the focus of the
PhD, only a portion of the data had been analyzed.
-
www.ahrq.gov/practiceimprovement/systemdesign/leancasestudies/lean-case4.html
November 01, 2014 - The case study methods, including selection criteria for projects to be analyzed, have been described
-
www.ahrq.gov/sites/default/files/publications2/files/measure-retirement-2013.pdf
January 01, 2013 - CCTAC analyzed the 2009 Medicaid Analytic eXtract (MAX) data to obtain
prevalence/incidence and cost
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
March 02, 2020 - treatment studies rather than randomized trials in this review because data from relevant DAA regimens were analyzed
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
June 11, 2019 - 12 , 18 , 31 , 33 , 39 , 42 There was also a strong association between effectiveness and adherence analyzed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6L2obA88s86MoZDbWtMPTU
December 01, 2011 - for cancer and 16 for fracture out-
comes) and 28 observational studies (for cancer outcomes) were
analyzed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/473PPVwoRhapCkN9SC-rue
May 18, 2021 - Analysis
Model output was analyzed in R version 3.6.1 (R Foundation for
Statistical Computing).
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/colorectal-cancer-screening-june-2016
June 15, 2016 - Output from each model was analyzed in RStudio version 0.98.1103.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
July 30, 2013 - Third, we analyzed rates of lung cancer and mortality by using the actual person-years of follow-up,
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/infusion-pumps-1.pdf
March 01, 2020 - The studies included in this review implemented or analyzed process
changes that were specific to the
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
February 13, 2018 - Analyzed
Ovarian Cancer Deaths,
No. (%)
Ovarian Cancer Mortality
per 10 000 Person-Years
Between-Group
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/home-dialysis-ESKD-rapid-research.pdf
April 01, 2025 - Another study from the French registry26 analyzed a subgroup of 1,613 older (>75 years)
PD patients
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
April 22, 2013 - Many of the studies that have looked at
cardiovascular and metabolic benefits of weight loss
have analyzed
-
digital.ahrq.gov/sites/default/files/docs/July%20Teleconference%20Transcript.pdf
June 16, 2021 - AHRQ 7/13/10 Page 1
Using Health IT to Prevent Adverse Effects
COLLIN BUCKLEY: Hello and welcome to the AHRQ webcast, Using
Health IT to Prevent Adverse Effects. At this point I’d like to introduce today’s
moderator, Doctor Amy Helwig. She’s a medical officer and leads the Patient
Safety Organizati…